http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22104810

Outgoing Links

Predicate Object
contentType English Abstract|Journal Article
endingPage 8
issn 0761-8425
issueIdentifier 8 Pt 2
pageRange 3S113-8
publicationName Revue des maladies respiratoires
startingPage 3S113
bibliographicCitation Quoix E. [Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer]. Rev Mal Respir. 2008 Oct;25(8 Pt 2):3S113–8. PMID: 18971835.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c181bc3f0d18f8db5df92ea0f71e693
date 200810
identifier https://pubmed.ncbi.nlm.nih.gov/18971835
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7114
https://portal.issn.org/resource/ISSN/0761-8425
language French
source https://pubmed.ncbi.nlm.nih.gov/
title [Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer]
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D002289Q000188
http://id.nlm.nih.gov/mesh/D002289Q000556
http://id.nlm.nih.gov/mesh/D008175Q000188
http://id.nlm.nih.gov/mesh/D008175Q000473
hasSubjectTerm http://id.nlm.nih.gov/mesh/D015996
http://id.nlm.nih.gov/mesh/D009367
http://id.nlm.nih.gov/mesh/D002289Q000473
http://id.nlm.nih.gov/mesh/D002289Q000401
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008175Q000401
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 38.